Menu
Back to User profile » Dr Xiaoyu Pan
Papers published by Dr Xiaoyu Pan:
Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice
Yang Y, Pan X, Chen S
Diabetes, Metabolic Syndrome and Obesity 2024, 17:1217-1233
Published Date: 11 March 2024
Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
Wang S, Pan X, Zhang M, Chen S
Diabetes, Metabolic Syndrome and Obesity 2024, 17:1-9
Published Date: 3 January 2024
Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy
Wang S, Pan X, Jia B, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3827-3836
Published Date: 24 November 2023
The Combination of Remnant Cholesterol and Waist Circumference Offers Predictive Value for Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Medical Examination Center
Jia Z, Pan X, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3459-3469
Published Date: 2 November 2023
Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy
Ban J, Pan X, Yang L, Jia Z, Zhen R, Zhang X, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2991-3005
Published Date: 27 September 2023
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2833-2834
Published Date: 16 September 2023
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2549-2560
Published Date: 24 August 2023
Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
Pan X, Jia Z, Zhen R, Yue L, Niu S, Ban J, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1941-1952
Published Date: 28 June 2023
Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
Pan X, Zhang X, Ban J, Yue L, Ren L, Chen S
Journal of Inflammation Research 2023, 16:1853-1865
Published Date: 27 April 2023
Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics
Pan X, Zhang X, Ban J, Yue L, Ren L, Chen S
Diabetes, Metabolic Syndrome and Obesity 2023, 16:873-882
Published Date: 28 March 2023
Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
Pan X, Yue L, Ban J, Ren L, Chen S
Journal of Inflammation Research 2022, 15:6409-6425
Published Date: 24 November 2022
Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study
Pan X, Yue L, Ren L, Ban J, Chen S
Diabetes, Metabolic Syndrome and Obesity 2022, 15:3519-3531
Published Date: 14 November 2022
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
Chen X, Chen S, Ren Q, Niu S, Pan X, Yue L, Li Z, Zhu R, Jia Z, Chen X, Zhen R, Ban J
Drug Design, Development and Therapy 2022, 16:3893-3913
Published Date: 9 November 2022
An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism
Ren Q, Chen S, Chen X, Niu S, Yue L, Pan X, Li Z, Chen X
Drug Design, Development and Therapy 2022, 16:3723-3735
Published Date: 25 October 2022
Correlation of Obesity and Overweight with Cervical Vascular Function Among Healthy Populations
Pan X, Chen X, Ren L, Li Z, Chen S
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2927-2938
Published Date: 25 September 2022
Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy
Chen X, Chen S, Li Z, Pan X, Jia Y, Hu Z, Niu K, Liu B, Ren Q
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1897-1909
Published Date: 20 June 2022